v3.25.2
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Nonvested Restricted Shares
A summary of changes in the Company’s nonvested restricted shares for the six months ended June 30, 2025 and June 30, 2024 follows:
SharesWeighted-Average
Grant-Date
Fair Value, per share
Nonvested at January 1, 2025
47,485 $14.54 
Granted
25,800 15.78 
Vested
(24,225)(13.23)
Forfeited
(540)(15.03)
Nonvested at June 30, 2025
48,520 $15.85 
SharesWeighted-Average
Grant-Date
Fair Value, per share
Nonvested at January 1, 2024
52,195 $18.75 
Granted
30,650 11.70 
Vested
(28,710)(18.50)
Forfeited
(1,025)(16.48)
Nonvested at June 30, 2024
53,110 $14.86 
Schedule of Activity in the Equity Plan
A summary of the activity in the Equity Plan for the six months ended June 30, 2025 and June 30, 2024 follows:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (in years)
Aggregate
Intrinsic
Value
Outstanding at January 1, 2025
364,063 $15.68 
Exercised
(1,050)(14.67)
Outstanding at June 30, 2025
363,013 $15.68 3.67$— 
Vested and exercisable at June 30, 2025
357,748 $15.69 3.65$— 
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (in years)
Aggregate
Intrinsic
Value
Outstanding at January 1, 2024
367,033 $15.68 
Forfeited
(1,575)(15.41)
Outstanding at June 30, 2024
365,458 $15.68 5.16$— 
Vested and exercisable at June 30, 2024
350,660 $15.71 5.12$—